A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 550
- 主要终点
- Symptoms monitoring
研究概览
简要总结
A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
详细描述
A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 16 Years 至 65 Years(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Having tested positive to Covid-19 on PCR test -
排除标准
- •Pregnancy Low blood pressure On immune system suppressing medications
结局指标
主要结局
Symptoms monitoring
时间窗: First 7 days after testing positive on PCR test
Monitoring any disease symptoms reported by patient
Covid-19 infection self-testing on days 2, 4 following testing positive on PCR test
时间窗: First 7 days after testing positive on PCR test
Testing using a self testing kit of the Quidel QuickView type
次要结局
未报告次要终点
